Calcium gluconate

Generic Name
Calcium gluconate
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C12H22CaO14
CAS Number
299-28-5
Unique Ingredient Identifier
SQE6VB453K
Background

Calcium gluconate is used as mineral supplement and medication when there is insufficient calcium in the diet. Supplementation may be done to treat or prevent osteoporosis or rickets, consequences of hypocalcemia. It can also be taken by mouth but is not recommended by injection into a muscle.
...

Indication

Oral calcium salts are used as dietary supplemental therapy for person who may not get enough calcium in their regular diet. Calcium gluconate is used as a cardioprotective agent in high blood potassium. Calcium gluconate is the antidote for magnesium sulfate toxicity.

Associated Conditions
Bone and tooth decay, Bone and tooth growth, Calcium Deficiency, Hypocalcemia, Nutritional Rickets, Osteomalacia, Osteoporosis, Otospongiosis, Postmenopausal Osteoporosis, Vitamin D Insufficiency, Vitamin D Resistant Rickets
Associated Therapies
-
Clinical Trials
Related News

Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer

First Posted Date
2006-12-28
Last Posted Date
2017-07-11
Lead Sponsor
University of Washington
Target Recruit Count
100
Registration Number
NCT00416715
Locations
🇺🇸

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Phase 3
Completed
Conditions
Breast Cancer
Osteoporosis
First Posted Date
2006-07-20
Last Posted Date
2020-04-02
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
497
Registration Number
NCT00354302
Locations
🇨🇦

Cambridge Memorial Hospital, Cambridge, Ontario, Canada

🇨🇦

Odette Cancer Centre, Toronto, Ontario, Canada

🇨🇦

St. Michael's Hospital, Toronto, Ontario, Canada

and more 10 locations

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery

First Posted Date
2006-04-21
Last Posted Date
2016-08-11
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
104
Registration Number
NCT00316914
Locations
🇺🇸

Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines, Iowa, United States

🇺🇸

Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines, Iowa, United States

🇺🇸

Avera Cancer Institute, Sioux Falls, South Dakota, United States

and more 11 locations

Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation

First Posted Date
2003-04-09
Last Posted Date
2020-12-08
Lead Sponsor
Northwestern University
Target Recruit Count
53
Registration Number
NCT00058188
Locations
🇺🇸

John H. Stroger Hospital of Cook County, Chicago, Illinois, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

🇺🇸

Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois, United States

Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects

First Posted Date
1999-10-19
Last Posted Date
2005-06-24
Lead Sponsor
National Center for Research Resources (NCRR)
Target Recruit Count
150
Registration Number
NCT00004361
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy